Wolverine Trading’s Immunic IMUX Stock Holding History

Wolverine Trading’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$10.2K	Buy	+1,095	New	+$9.66K	﹤0.01%	5556
2025 Q1	–	Sell	-1,679	Closed	-$17.3K	–	5238
2024 Q4	$17.3K	Buy	1,679 +510	+44%	+$6.43K	﹤0.01%	5121
2024 Q3	$18.1K	Buy	+1,169	New	+$16.6K	﹤0.01%	4652
2024 Q1	–	Sell	-1,093	Closed	-$16.4K	–	4845
2023 Q4	$16.4K	Buy	+1,093	New	+$13.4K	﹤0.01%	4383
2023 Q3	–	Sell	-1,815	Closed	-$41.7K	–	4777
2023 Q2	$41.7K	Buy	+1,815	New	+$30.4K	﹤0.01%	3989
2022 Q2	–	Sell	-1,146	Closed	-$132K	–	5079
2022 Q1	$132K	Buy	1,146 +112	+11%	+$13K	﹤0.01%	4689
2021 Q4	$99K	Buy	+1,034	New	+$93.1K	﹤0.01%	5095

Other funds holding IMUX

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wolverine Trading's IMUX Position: Q3 2025 in Review

Wolverine Trading opened a new position in Immunic (IMUX) in Q3 2025: 1,095 shares worth $10.2K. The stake represents ﹤0.01% of the portfolio and ranks #5556 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in IMUX as recently as Q4 2024.

Wolverine Trading first reported a position in IMUX in Q4 2021 and has held it in 7 quarters since. The position peaked at $132K in Q1 2022. 59 funds tracked by Wall St. Rank hold IMUX as of Q3 2025.

Wolverine Trading held 1,095 shares of Immunic worth $10.2K as of Q3 2025.
Immunic was a new Wolverine Trading position in Q3 2025.
Immunic made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5556 holding.
Wolverine Trading first reported a position in Immunic in Q4 2021 and has held it in 7 quarters since.
Wolverine Trading's Immunic position peaked at $132K in Q1 2022.
59 funds tracked by Wall St. Rank held Immunic as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.